Keymed Biosciences Inc. (2162.HK)

HKD 48.0

(7.5%)

Operating Income Summary of Keymed Biosciences Inc.

Keymed Biosciences Inc.'s latest annual operating income in 2023 was -434.8 Million CNY , down -54.86% from previous year.
Keymed Biosciences Inc.'s latest quarterly operating income in 2024 Q2 was -196.63 Million CNY , down 0.0% from previous quarter.
Keymed Biosciences Inc. reported an annual operating income of -295.37 Million CNY in 2022, up 92.39% from previous year.
Keymed Biosciences Inc. reported an annual operating income of -3.88 Billion CNY in 2021, down -382.35% from previous year.
Keymed Biosciences Inc. reported a quarterly operating income of -196.63 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Keymed Biosciences Inc. reported a quarterly operating income of -218.51 Million CNY for 2023 Q3, down -2041.97% from previous quarter.

Annual Operating Income Chart of Keymed Biosciences Inc. (2023 - 2019)

Historical Annual Operating Income of Keymed Biosciences Inc. (2023 - 2019)

Year	Operating Income	Operating Income Growth
2023	-434.8 Million CNY	-54.86%
2022	-295.37 Million CNY	92.39%
2021	-3.88 Billion CNY	-382.35%
2020	-804.7 Million CNY	-396.12%
2019	-162.19 Million CNY	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	-196.63 Million CNY	9.81%
2024 Q2	-196.63 Million CNY	0.0%
2023 Q3	-218.51 Million CNY	-2041.97%
2023 FY	-457.43 Million CNY	-54.86%
2023 Q4	-218.02 Million CNY	0.22%
2023 Q1	-10.2 Million CNY	95.22%
2023 Q2	-10.2 Million CNY	0.0%
2022 Q2	-58.79 Million CNY	0.0%
2022 FY	-295.37 Million CNY	92.39%
2022 Q1	-58.79 Million CNY	17.32%
2022 Q4	-213.44 Million CNY	0.0%
2022 Q3	-213.44 Million CNY	-263.03%
2021 FY	-3.88 Billion CNY	-382.35%
2021 Q4	-71.11 Million CNY	0.0%
2021 Q3	-71.11 Million CNY	34.84%
2021 Q2	-109.13 Million CNY	0.0%
2021 Q1	-109.13 Million CNY	-115.34%
2020 Q4	-50.68 Million CNY	0.0%
2020 FY	-804.7 Million CNY	-396.12%
2020 Q2	-23.8 Million CNY	0.0%
2020 Q3	-50.68 Million CNY	-112.88%
2020 Q1	-23.8 Million CNY	0.0%
2019 FY	-162.19 Million CNY	0.0%

Peer Operating Income Comparison of Keymed Biosciences Inc.

Name	Operating Income	Operating Income Difference
Uni-Bio Science Group Limited	67.76 Million HKD	741.601%
CK Life Sciences Int'l., (Holdings) Inc.	897.95 Million HKD	148.421%